// company-profile
Unicycive Therapeutics, Inc.
UNCYExchangeNasdaqSectorPharmaceutical PreparationsInc.DEFilings43Insiders9
// api This Unicycive Therapeutics, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.
// activity-summary
No insider transactions in the last 30 days.
// 90-day insight
Over the last 90 days, Unicycive Therapeutics, Inc. insiders bought $0 across 8 transactions with no open-market sales.
- Most active insider: Laumas Sandeep with 2 transactions totaling $0.
Activity skews bullish — buys outpace sales.
Institutional Ownership
Top 13F-HR holders of Unicycive Therapeutics, Inc. as of 2026-03-31
Total reported AUM
$67.9M
QoQ change
+44.1%
Reporting period
2026-03-31
#1
Vivo Capital, LLC
CIK 1674712
$11.8M
1.8M shares
#2
MILLENNIUM MANAGEMENT LLC
CIK 1273087
$9.2M
1.4M shares
#3
Octagon Capital Advisors LP
CIK 1839435
$6.6M
1.0M shares
Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 14, 2026 | Laumas Sandeep | UNCY | Award | 84,200 | $0.00 | $0K |
| May 14, 2026 | Laumas Sandeep | UNCY | Award | 42,100 | $0.00 | $0K |
| May 14, 2026 | Gupta Pramod | UNCY | Award | 169,500 | $0.00 | $0K |
| May 14, 2026 | Townsend John | UNCY | Award | 169,500 | $0.00 | $0K |
| May 14, 2026 | Jermasek Douglas | UNCY | Award | 169,500 | $0.00 | $0K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Popular companies on Form4API
Browse insider trading activity for other actively-filed companies.